Psychiatry

The drug is being tested for the first time on a large scale adult patient population.

In response to patient concerns about dosing options and duration of effect, researchers at Shire Pharmaceuticals created Mydayis for the treatment of ADHD symptoms.

Alnylam Therapeutics expects to file for a New Drug Application in late 2017.

Psychedelics like psilocybin have been receiving attention from psychiatrists on and off for decades. Here's what we've learned, and what's on the horizon.

Parental rejection, abandonment, physical and sexual abuse double the victim's rates of depression, inflammation, metabolic disorders and chronic medical illnesses.

Patients struggling with addiction can be difficult to treat. Following best practices can help simplify a complex process.

The drug showed improved symptoms across multiple doses in a 6-month study.

Doris Greenberg, MD, discusses the fine line between Asperger's Syndrome and Autism Spectrum Disorder.

The treatment is a once-daily, extended-release liquid medication, but does not require refrigeration or pharmacy reconstitution.

The study authors theorized that there are further connections between age and HA, with older adults having significantly more HA than younger adults.

Using 24-hour wrist monitors, the study revealed “distinct mood-dependent effects on wrist-activity markers of circadian timekeeping.”

Cleveland Clinic physicians weigh in on their best methods for maintaining a good doctor-patient relationship.

These tools can reduce selection bias and misdiagnosis, and improve communication between primary and secondary care physicians.

12% of patients prescribed the 2 drugs in combination were still taking benzodiazepine 6 months later.

Their doubts may negatively affect their interest in creating teams of specialized physicians to help those patients.

Though safer for relapsing-remmitting multiple sclerosis than new disease-modifying therapies, the treatment nearly doubles the chance of a patient suffering from a stroke.

MS patients were significantly outscored by a control group in a series of social interaction tests.

Two blood proteins have shown a combined 82% accuracy in diagnosing ASD in a group of pediatric patients.

Allen Bowling, MD, PhD, explains the benefits and roadblocks of alternative medicine for MS.

A father's age can negatively affect the social development of his child.

Dr. Kiki Chang sits down with MD Magazine and talks about the latest data on lurasidone.

Leading eating disorder expert Evelyn Attia, MD, sat down with MD Mag at the American Psychiatric Association meeting to talk about the correlation between obesity and eating disorders.

Telepsychiatry shown to be viable alternative in rural areas with limited access.

Transcranial Magnetic Stimulation (TMS) is getting good results as an adjunctive therapy for patients with major depression who have failed on several antidepressant medications.

Dr. Melissa Arbuckle explains what neuroscience is and why every practicing psychiatrist should have an understanding and appreciation for this branch of science.